Last reviewed · How we verify
NCT06921863: DoItAgain
This Study Aims to Quantify Decisional Regret as Well as Quality of Life in Patients With Low- to High-risk Cancer and High Burden of Symptoms Undergoing Radiotherapy Using Established Questionnaires.
trial in Quality of Life (QOL) in 165 participants. Not yet recruiting.
1 October 2029
Quick facts
| Lead sponsor | University Medical Center Goettingen |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 165 |
| Start date | 1 July 2025 |
| Primary completion | 1 October 2029 |
| Estimated completion | 1 October 2032 |
Conditions studied
- Quality of Life (QOL) — all drugs for Quality of Life (QOL) →
- Decision Making ,Shared — all drugs for Decision Making ,Shared →
Sponsor
University Medical Center Goettingen
Who can join
18 and older, any sex, with Quality of Life (QOL) or Decision Making ,Shared. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this prospective registry study, patients with low-, intermediate- and high-risk tumor entities as well as patients with high symptom burden of any tumor entity in palliative constellation with indication for radiation treatment are included. This radiation treatment can be applied either as 3D-conformal RT or IGRT. The duration of treatment can range from one day to several weeks. For the primary endpoint as well as the secondary clinical and other exploratory endpoints, the 3 groups will be compared in terms of DR, QoL, toxicities and treatment plan parameters
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06921863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Quality of Life (QOL)
Currently open trials in the same condition.
- NCT07210164 — Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study · NA · recruiting
- NCT06939426 — Music Therapy and Humanization in ED Healthcare Professionals · NA · recruiting
- NCT07027930 — A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative Treatment Group Protocol for O · NA · recruiting
- NCT07010939 — A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients · recruiting
- NCT06886451 — Vomiting Prevention in Children With Cancer · NA · recruiting
Other University Medical Center Goettingen trials
Trials by the same sponsor.
- NCT07505498 — Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set · recruiting
- NCT07008677 — Oral Health Awareness and Status Among Professional Musicians in German Orchestras · completed
- NCT07529041 — Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging · NA · enrolling by invitation
- NCT07476365 — A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A) · recruiting
- NCT07056738 — Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06921863 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Center Goettingen
- Last refreshed: 10 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06921863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing